Indeed, our data here clearly demonstrate that Peptide B-8R causes increased p53 protein levels in prostate cancer cells, consistent with the hypothesis that Peptide B-8R binds to sGCα1 and disrupts the complex activity on p53. This evidence concerns the gene TP53 and prostate cancer.